Pregled bibliografske jedinice broj: 654054
Donor human milk for preterm infants: current evidence and research directions
Donor human milk for preterm infants: current evidence and research directions // Journal of pediatric gastroenterology and nutrition, 57 (2013), 535-42 doi:10.1097/MPG.0b013e3182a3af0a (podatak o recenziji nije dostupan, članak, ostalo)
CROSBI ID: 654054 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Donor human milk for preterm infants: current evidence and research directions
Autori
Arslanoglu S ; Corpeleijn W ; Moro G ; Braegger C ; Campoy C ; Colomb V ; Decsi T ; Domellöf M ; Fewtrell M ; Hojsak, Iva ; Mihatsch W ; Mølgaard C ; Shamir R ; Turck D ; van Goudoever J.
Izvornik
Journal of pediatric gastroenterology and nutrition (0277-2116) 57
(2013);
535-42
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
human milk
Sažetak
The Committee on Nutrition of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition aims to document the existing evidence of the benefits and common concerns deriving from the use of donor human milk (DHM) in preterm infants. The comment also outlines gaps in knowledge and gives recommendations for practice and suggestions for future research directions. Protection against necrotizing enterocolitis is the major clinical benefit deriving from the use of DHM when compared with formula. Limited data also suggest unfortified DHM to be associated with improved feeding tolerance and with reduced cardiovascular risk factors during adolescence. Presence of a human milk bank (HMB) does not decrease breast-feeding rates at discharge, but decreases the use of formula during the first weeks of life. This commentary emphasizes that fresh own mother's milk (OMM) is the first choice in preterm infant feeding and strong efforts should be made to promote lactation. When OMM is not available, DHM is the recommended alternative. When neither OMM nor DHM is available, preterm formula should be used. DHM should be provided from an established HMB, which follows specific safety guidelines. Storage and processing of human milk reduces some biological components, which may diminish its health benefits. From a nutritional point of view, DHM, like HM, does not meet the requirements of preterm infants, necessitating a specific fortification regimen to optimize growth. Future research should focus on the improvement of milk processing in HMB, particularly of heat treatment ; on the optimization of HM fortification ; and on further evaluation of the potential clinical benefits of processed and fortified DHM.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
072-1083107-2054 - Celijakija u djece: primarna prevencija i patogeneza kromosomske nestabilnosti (Kolaček, Sanja, MZOS ) ( CroRIS)
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta
Profili:
Iva Hojsak
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE